Skip to main
UHS
UHS logo

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 17%
Hold 58%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services Inc. reported a 21% year-over-year growth in adjusted EBITDA for its Acute Care Hospital Services segment, primarily due to robust topline growth and effective cost management, leading to a 150 basis point expansion in the same-store adjusted EBITDA margin to 15.7%. The Behavioral Health Services segment also saw positive performance, with same-store revenue growth of 5.5% and an increase in adjusted EBITDA margin by 40 basis points to 23.0%. Additionally, management expressed optimism regarding the approval of new programs in non-UHS states, which may further enhance revenue opportunities moving forward.

Bears say

Universal Health Services faces significant challenges that contribute to a negative outlook, primarily due to anticipated volume and margin headwinds that could lead to earnings being approximately 5% lower than current estimates for FY25. The company has reported a decline in critical metrics, with adjusted admissions down 1.6% and adjusted patient days decreasing by 0.3%, indicating weakened demand in its behavioral health services segment. Furthermore, despite a modest revenue growth rate of 2.5% per adjusted admission, the enterprise multiple of around 6.0x reflects trough levels consistent with last year's performance, signaling persistent market concerns over the firm’s financial stability.

UHS has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 17% recommend Buy, 58% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 12 analysts, UHS has a Hold consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $224.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $224.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.